Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Knockdown of Long Non-Coding RNA UCA1 Increases the Tamoxifen Sensitivity of Breast Cancer Cells through Inhibition of Wnt/β-Catenin Pathway
Hongying Liu, Gang Wang, Lili Yang, et al.
PLoS ONE (2016) Vol. 11, Iss. 12, pp. e0168406-e0168406
Open Access | Times Cited: 126

Showing 1-25 of 126 citing articles:

Long Noncoding RNA and Cancer: A New Paradigm
Arunoday Bhan, Milad Soleimani, Subhrangsu S. Mandal
Cancer Research (2017) Vol. 77, Iss. 15, pp. 3965-3981
Open Access | Times Cited: 2484
Long Non-Coding RNA in the Pathogenesis of Cancers
Yujing Chi, Di Wang, Junpei Wang, et al.
Cells (2019) Vol. 8, Iss. 9, pp. 1015-1015
Open Access | Times Cited: 705
Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells
Richard Heery, Stephen P. Finn, Sinéad Cuffe, et al.
Cancers (2017) Vol. 9, Iss. 4, pp. 38-38
Open Access | Times Cited: 183
Long non-coding RNA mediated drug resistance in breast cancer
Deepshikha Singh, Yehuda G. Assaraf, Rajesh N. Gacche
Drug Resistance Updates (2022) Vol. 63, pp. 100851-100851
Closed Access | Times Cited: 94
Unveiling the connection: Long-chain non-coding RNAs and critical signaling pathways in breast cancer
Riya Thapa, Obaid Afzal, Gaurav Gupta, et al.
Pathology - Research and Practice (2023) Vol. 249, pp. 154736-154736
Closed Access | Times Cited: 78
LncRNA UCA1 in anti-cancer drug resistance
Haohao Wang, Zhonghai Guan, Kuifeng He, et al.
Oncotarget (2017) Vol. 8, Iss. 38, pp. 64638-64650
Open Access | Times Cited: 137
Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs
Wenxiao Jiang, Jun Xia, Shangdan Xie, et al.
Drug Resistance Updates (2020) Vol. 50, pp. 100683-100683
Closed Access | Times Cited: 115
LncRNA MEG3 enhances cisplatin sensitivity in non-small cell lung cancer by regulating miR-21-5p/SOX7 axis
Pei Wang, Dong Chen, Hongbing Ma, et al.
OncoTargets and Therapy (2017) Vol. Volume 10, pp. 5137-5149
Open Access | Times Cited: 109
Knockdown of LncRNA‐UCA1 suppresses chemoresistance of pediatric AML by inhibiting glycolysis through the microRNA‐125a/hexokinase 2 pathway
Yuan Zhang, Yufeng Liu, Xueju Xu
Journal of Cellular Biochemistry (2018) Vol. 119, Iss. 7, pp. 6296-6308
Closed Access | Times Cited: 102
Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications
Huibin Song, Dongcheng Liu, Shaowei Dong, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 101
The Network of Non-coding RNAs in Cancer Drug Resistance
Fabio Corrà, Chiara Agnoletto, Linda Minotti, et al.
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 99
Roles of miRNA and IncRNA in triple-negative breast cancer
Juan Xu, Kangjing Wu, Qiaojun Jia, et al.
Journal of Zhejiang University SCIENCE B (2020) Vol. 21, Iss. 9, pp. 673-689
Open Access | Times Cited: 99
The Impact of lncRNA Dysregulation on Clinicopathology and Survival of Breast Cancer: A Systematic Review and Meta-analysis
Tian Tian, Meng Wang, Shuai Lin, et al.
Molecular Therapy — Nucleic Acids (2018) Vol. 12, pp. 359-369
Open Access | Times Cited: 96
Emerging roles of long noncoding RNAs in chemoresistance of pancreatic cancer
Wangkai Xie, Man Chu, Gendi Song, et al.
Seminars in Cancer Biology (2020) Vol. 83, pp. 303-318
Closed Access | Times Cited: 96
Long non‑coding RNA UCA1 confers tamoxifen resistance in breast cancer endocrinotherapy through regulation of the EZH2/p21 axis and the PI3K/AKT signaling pathway
Zhuo Li, Dehai Yu, Haijun Li, et al.
International Journal of Oncology (2019)
Open Access | Times Cited: 88
lncRNA and breast cancer: Progress from identifying mechanisms to challenges and opportunities of clinical treatment
Xin Jin, Wei Du, Wentao Huang, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 25, pp. 613-637
Open Access | Times Cited: 81
Non-coding RNAs as potential therapeutic targets in breast cancer
Deepti Tomar, Amit Singh Yadav, Dhiraj Kumar, et al.
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2019) Vol. 1863, Iss. 4, pp. 194378-194378
Closed Access | Times Cited: 78
Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability
Giasemi C. Eptaminitaki, Dimitris Stellas, Benjamin Bonavida, et al.
Drug Resistance Updates (2022) Vol. 65, pp. 100866-100866
Closed Access | Times Cited: 51
Biological functions and molecular interactions of Wnt/β-catenin in breast cancer: Revisiting signaling networks
Mehrdad Hashemi, Sahar Hasani, Shima Hajimazdarany, et al.
International Journal of Biological Macromolecules (2023) Vol. 232, pp. 123377-123377
Closed Access | Times Cited: 25
Resveratrol inhibits proliferation, migration and invasion of multiple myeloma cells via NEAT1-mediated Wnt/β-catenin signaling pathway
Weizheng Geng, Xin Guo, Lirong Zhang, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 107, pp. 484-494
Closed Access | Times Cited: 81
Long non-coding RNA XIST promotes cell growth and metastasis through regulating miR-139-5p mediated Wnt/β-catenin signaling pathway in bladder cancer
Yangyang Hu, Chao Deng, He Zhang, et al.
Oncotarget (2017) Vol. 8, Iss. 55, pp. 94554-94568
Open Access | Times Cited: 77
Serum long noncoding RNA urothelial carcinoma-associated 1: A novel biomarker for diagnosis and prognosis of hepatocellular carcinoma
Zhikun Zheng, Cui Pang, Yang� Yang, et al.
Journal of International Medical Research (2017) Vol. 46, Iss. 1, pp. 348-356
Open Access | Times Cited: 73
<p>The prognostic value and mechanisms of lncRNA UCA1 in human cancer</p>
Fei Yao, Qiang Wang, Qingming Wu
Cancer Management and Research (2019) Vol. Volume 11, pp. 7685-7696
Open Access | Times Cited: 73
Highly expressed long non-coding RNA FOXD2-AS1 promotes non-small cell lung cancer progression via Wnt/β-catenin signaling
Lin Rong, Ruixing Zhao, Jinxiu Lu
Biochemical and Biophysical Research Communications (2017) Vol. 484, Iss. 3, pp. 586-591
Closed Access | Times Cited: 70
The roles of Wnt/β-catenin signaling pathway related lncRNAs in cancer
Xiaoyi Hu, Pingfu Hou, Teng-Teng Li, et al.
International Journal of Biological Sciences (2018) Vol. 14, Iss. 14, pp. 2003-2011
Open Access | Times Cited: 70
Page 1 - Next Page

Scroll to top